医疗影像模型市场（按产品类型、材料、应用和最终用户划分）—全球预测 2025-2032

预计到 2032 年，医学影像模型市场规模将成长至 3.4361 亿美元，复合年增长率为 6.92%。

主要市场统计数据
基准年2024年	2.0112亿美元
预计2025年	2.1535亿美元
预测年份：2032年	3.4361亿美元
复合年增长率（%）	6.92%

医学影像模型的全面基础概述突显了技术发展、临床作用、检验要求和相关人员的策略重点

医学影像模型是诊断和介入工作流程中必不可少的工具，它连接着技术开发、临床检验和操作员培训。这些人工构建体能够复製解剖结构、组织特性和放射学反应，为设备校准、成像通讯协定检验和跨学科团队培训提供可重复和检验的条件。随着显像模式在解析度、速度和功能方面的不断发展，模型的作用正从简单的几何物件扩展到反映现代临床需求的复杂多模态测试物件。

在这种环境下，从设备製造商到临床终端使用者的相关人员纷纷转向使用体模，以降低风险、加快监管审批并优化规模化效能。过去十年，材料科学和製造技术的进步使得更忠实地模拟组织异质性、分子造影行为和声学特性。因此，体模已深度融入研究流程和常规品质保证计划。以下分析总结了这些动态，并为寻求了解体模生态系统中当前优先事项、新兴机会和营运考虑的领导者提供了简洁的指导。

深入分析重塑幻影格局的关键转型变化，包括积层製造、人工智慧验证、材料科学和监管融合

医学影像模型的领域正在经历数次变革，技术发展轨迹和商业性重点也随之改变。积层製造技术能够快速迭代以前无法实现的复杂形态和内部结构，使开发人员能够更快地製作原型并检验特定于设备的功能。同时，先进材料，尤其是那些能够更好地模拟介电、声学和放射密度特性的材料，使模型能够展现混合成像平台所需的多物理场行为。

同时，数据驱动的方法正在影响检验过程。用于影像重建和解读的机器学习模型需要多样化、註释的资料集来进行稳健的训练和效能评估。这项要求促使人们设计体模，以产生跨模态的可重复、可量化的真实数据。监管和临床相关人员也在就标准化测试通讯协定达成共识，从而提升了经过认证的可重复体模的价值。最后，供应链透明度和永续性考量如今指南采购决策，鼓励製造商优化材料采购和生命週期影响。总而言之，这些转变正在创造一个由技术创新、检验严谨性和营运弹性决定竞争优势的格局。

研究 2025 年美国关税对整个 Phantom 生态系统的供应链筹资策略和製造本地化决策的累积影响

2025年美国关税的实施，对影像模型製造商及其买家的全球供应链和筹资策略造成了直接压力。某些进口零件和原材料的关税上调，促使企业重新评估其供应商布局，评估近岸外包选项，并加快替代供应商的资格审查流程。由于买家进行了额外的合规性检查，并试图了解现有采购安排对总到岸成本的影响，实际采购週期暂时延长。

作为应对，製造商加大了关键工艺的本地化力度，尤其是那些受关税影响最大的精密加工、成型和材料复合工艺。此类调整通常需要投资国内产能，或在低风险地区取得二级供应商的资格。重要的是，关税环境强调合约灵活性和库存策略作为战术性槓桿。拥有快速反应的物流和多元化供应商关係的企业更有可能保持供应的连续性并保障产品开发进度。展望未来，关税将成为更稳健供应链设计的催化剂，而非永久转向保护主义。

深入的细分综合揭示了产品类型、材料科学应用重点和最终用户行为如何与工程选择、采购动态和服务模式融合

細項分析揭示了产品类型差异化、材料选择、应用重点和最终用户特征如何影响开发优先顺序和购买行为。在产品类型中，电脑断层扫描专用模型优先考虑高对比度病变模拟和衰减精度，而磁共振模型则强调弛豫参数保真度和磁化率控制。核子医学影像模型需要精确的放射性分布和衰减特性，而PET模型必须考虑符合率和正微波效应。超音波模型需要高度可重复的声电阻和背向散射特性，X射线模型必须在几何保真度和放射密度校准需求之间取得平衡。因此，每种产品类型都需要製造商必须解决的独特工程权衡和检验通讯协定。

材料选择进一步影响性能范围和生命週期特性。丙烯酸和环氧树脂系统可提供稳定、可加工的平台，适合长期品质保证工作；而水凝胶配方则具有类似组织的柔软度和频率相关的声学特性，适用于超音波应用。塑胶复合材料和弹性体/橡胶可实现灵活的配置和可重复的机械响应，使其成为培训和模拟模组的必备材料。材料特性与应用（无论是设备检验、品质保证、研究、培训或教育）之间的相互作用决定了可接受的公差、老化特性和维护要求。

按应用细分凸显了不同的价值提案。设备测试和品质保证需要严格的可重复性和可追溯的校准标准，强调长期稳定性和可认证的性能。研究应用通常需要可自订的模组化模型，允许控制参数变化以支持假设驱动的研究。训练和教育优先考虑人体工学的真实性、经济高效的可重复性和可重复使用的安全操作。最后，最终用户表现出不同的购买行为。学术和研究机构通常优先考虑实验设置和数据访问，诊断中心优先考虑操作可靠性和吞吐量，医院优先考虑跨专业适用性和法规遵从性，而製药公司则需要支援成像生物标誌物检验和测试可重复性的模型。了解这些相交的细分轴可以使有针对性的产品策略和服务模式与相关人员的特定优先事项保持一致。

美洲、欧洲、中东和非洲以及亚太地区的战略洞察揭示了采用驱动因素、监管重点、製造优势和采购模式

区域动态对整个模型领域的技术采用、监管预期和製造策略有重大影响。在美洲，研发中心和成熟的临床基础设施正在推动对高保真度、合规模型的需求，这些模型既支援设备验证，也支援临床培训计画。该地区的采购流程越来越注重合规性文件、国内供应的连续性和供应商的透明度，这使得提供认证产品和快速售后服务的製造商受益。

在欧洲、中东和非洲，监管协调和对临床标准化的重视为支持跨境验证和多中心测试的体模创造了机会。在欧洲市场，永续性和生命週期报告通常被优先考虑，鼓励供应商记录材料的来源及其使用后的管道。相较之下，中东和非洲的临床成熟度和基础设施需求水准参差不齐，因此对可扩展且经济高效的体模的需求强劲，以配合培训和基本的品质保证计画。

亚太地区临床应用的快速发展与强大的製造能力相结合，使其成为模体技术的主要消费和生产地。该地区在精密製造和材料加工方面的能力支撑着区域供应链，而对大型成像网路和研究项目的投资则刺激了对先进的、特定于医疗器材的模体的需求。排放和供应链韧性等区域优先事项正日益影响采购框架，鼓励製造商展示技术性能和环境管理能力。

推动竞争优势和长期客户关係的创新重点伙伴关係策略认证和服务差异化主要企业的竞争考察

公司层面的动态揭示了市场参与企业中几个反覆出现的策略主题。首先，创新週期越来越多地围绕着材料工程和製造灵活性。领导者正在投资专有复合材料和製造方法，以实现快速定制，同时保持检验的完整性。其次，与临床中心和设备原始设备製造商的伙伴关係加速了产品的改进，并方便取得能够证明实际性能的检验数据。这些合作管道缩短了开发和临床验收之间的回馈循环。

第三，服务和认证管道能够带来显着的差异化。将全面的校准服务、技术培训计画和记录在案的验证通讯协定融入其产品的公司，能够增强客户维繫并创造经常性收益来源。最后，供应链管理和品质系统的卓越运作仍然至关重要，尤其是在受监管的司法管辖区。保持清晰的可追溯性、强大的变更管理和响应迅速的售后服务的公司更有可能与大型医疗保健系统和跨国研究联盟签订长期合约。

产业领导者应采取实际行动，加强供应链弹性，加速材料创新，扩大临床伙伴关係，拓宽以服务为基础的差异化

行业领导者可以在多个方面采取果断行动，以确保可持续成长并降低新兴风险。首先，他们应优先考虑供应链多元化，透过评估互补地区的多家供应商，并选择性地投资关键零件的近岸生产能力。这些措施将在保持开发弹性的同时，降低贸易政策波动所带来的风险。其次，他们正在加快对材料研发和积层製造能力的投资，以实现更高保真度、与模态无关的模型，并缩短客製化应用的设计週期。

第三，我们将深化临床伙伴关係，共同製定验证通讯协定，并将模型纳入早期设备测试和训练课程。第四，我们将透过整合技术培训、校准和资料打包来增强我们的服务，从而为最终用户缩短部署时间并降低操作复杂性。第五，我们将积极与监管和标准组织合作，以影响测试方法，并确保新产品符合不断变化的需求。最后，我们将在材料采购和包装方面采用可衡量的永续性实践，以满足日益增长的采购预期，并减少生命週期的环境影响。

透明而严谨的调查方法，描述了用于确保可靠性和有效性的主要访谈、技术检验、文献综合、同行评审和三角测量技术

本分析所依据的调查方法结合了质性与技术方法，以确保严谨性和有效性。主要证据来自对临床医生、采购负责人、技术总监和材料科学家的结构化访谈，从而提供对性能预期和操作限制的背景理解。二级资讯来源包括同行评审文献、标准文件和技术白皮书，这些资料有助于深入了解验证实践和材料性能特征。

技术检验包括实验室评估和供应商能力评估，以检验关于材料稳定性、尺寸精度和模态相容性的声明。跨资料流（访谈、技术检查和文献）的三角测量支持对趋势的稳健解读，并减少单一来源偏差。在此过程中，专家小组审查了初步研究结果，以确认其实际相关性并突出需要进一步研究的领域。调查方法认识到快速发展的技术的固有局限性，并建议定期重新评估以捕捉快速的创新週期。

简要总结结论，强调了对材料检验供应链弹性、监管协调和临床伙伴关係进行全面投资的必要性。

总而言之，医学影像体模领域正处于曲折点，材料创新、製造敏捷性和以服务主导的差异化将决定策略成果。体模在设备验证、临床培训和演算法效能评估中发挥越来越重要的作用，而围绕特定医疗模式需求和最终用户工作流程设计产品的相关人员正获得更广泛的应用。供应链弹性和监管合规性与技术卓越性相辅相成，构成了规模化营运所需的基础。

因此，决策者应该专注于将技术创新与强大的验证、敏捷的供应链设计和强大的临床伙伴关係关係相结合的整合策略，以便组织不仅可以解决短期中断，还可以获得具有可重复性能、监管准备和明显营运优势的解决方案所带来的长期价值。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

• 越来越多地采用针对患者的 3D 列印模型来确保个人化放射治疗的质量
• 增强人工智慧驱动的图像模型集成，以标准化 CT 和 MRI 性能指标
• 开发与 MRI、CT、超音波和 PET 相容的综合多模态成像模型，用于扫描仪校准
• 人们对模仿儿科解剖结构的拟人模型的需求日益增长，以优化儿科影像的剂量管理。
• 用于建构高保真超音波和弹性成像模型的仿生组织等效材料的进展
• 扩展虚拟和数位模型平台，用于影像重建演算法检验和临床工作流程培训
• 学术研究机构和製造商合作设计用于新模态测试的可自订模型
• 监管重点是标准化的基于模型的品管通讯协定，以确保各中心之间可重复的成像性能

第六章 2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 医疗影像模型市场（依产品类型）

• CT体模
• MRI体模
• 核子成像体模
• PET体模
• 超音波模
• X射线模型

9. 医学影像模型市场（按材料）

• 丙烯酸纤维
• 环氧树脂
• 水凝胶
• 塑胶
• 橡皮

第 10 章：医学影像模型市场（按应用）

• 设备测试
• 品质保证
• 研究
• 培训和教育

第 11 章 医学影像模型市场（依最终使用者）

• 学术研究机构
• 诊断中心
• 医院
• 製药公司

12. 医学影像模型市场（按地区）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章 医学影像模式市场（按类别）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

14. 各国医学影像模型市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章竞争格局

• 2024年市占率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Computerized Imaging Reference Systems, Inc.
  • Sun Nuclear Corporation
  • Standard Imaging, Inc.
  • Kyoto Kagaku Co., Ltd.
  • Modus Medical Devices Inc.
  • PTW-Freiburg GmbH
  • Phantom Laboratory, Inc.
  • Tissue Simulation Technology, LLC
  • Radiation Imaging Technology, Inc.
  • Fluke Biomedical

The Medical Imaging Phantoms Market is projected to grow by USD 343.61 million at a CAGR of 6.92% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 201.12 million
Estimated Year [2025]	USD 215.35 million
Forecast Year [2032]	USD 343.61 million
CAGR (%)	6.92%

Comprehensive foundational overview of medical imaging phantoms that clarifies technological evolution clinical roles validation requirements and strategic priorities for stakeholders

Medical imaging phantoms serve as indispensable instruments bridging technology development, clinical validation, and operator training across diagnostic and interventional workflows. These engineered constructs replicate anatomical structures, tissue properties, and radiological responses to provide repeatable, verifiable conditions for calibrating devices, validating imaging protocols, and educating multidisciplinary teams. As imaging modalities evolve in resolution, speed, and functionality, the role of phantoms expands beyond simple geometric targets to complex, multimodal test objects that reflect the demands of contemporary clinical practice.

Within this context, stakeholders ranging from device manufacturers to clinical end users rely on phantoms to reduce risk, accelerate regulatory clearance, and optimize performance at scale. Over the past decade, improvements in materials science and manufacturing techniques have enabled higher-fidelity simulation of tissue heterogeneity, molecular contrast behavior, and acoustic properties. Consequently, phantoms now support deeper integration into research pipelines and routine quality assurance programs. The following analysis synthesizes these dynamics to provide a succinct orientation for leaders seeking to understand immediate priorities, emerging opportunities, and operational considerations in the phantom ecosystem.

Detailed analysis of the major transformative shifts reshaping the phantom landscape including additive manufacturing AI validation materials science and regulatory convergence

Several transformative shifts are actively reshaping the landscape for medical imaging phantoms, altering both technological trajectories and commercial priorities. Additive manufacturing now enables rapid iteration of complex geometries and internal structures that were previously infeasible, and as a result, developers can prototype and validate modality-specific features with greater speed. At the same time, advanced materials-particularly those that better mimic dielectric, acoustic, or radiodensity properties-allow phantoms to exhibit multi-physics behavior required for hybrid imaging platforms.

Concurrently, data-driven approaches influence validation processes; machine learning models used in image reconstruction and interpretation demand diverse, annotated datasets for robust training and performance evaluation. This requirement incentivizes phantoms designed to produce reproducible, quantifiable ground truth across modalities. Regulatory and clinical stakeholders are also converging on standardized test protocols, which increases the value of certified, repeatable phantoms. Finally, supply chain transparency and sustainability considerations now guide procurement decisions, encouraging manufacturers to optimize material sourcing and lifecycle impacts. Taken together, these shifts create a landscape in which innovation, validation rigor, and operational resiliency determine competitive advantage.

Examination of the cumulative effects of United States tariff actions from 2025 on supply chains procurement strategies and manufacturing localization decisions across the phantom ecosystem

The introduction of United States tariff measures in 2025 created immediate pressure on global supply chains and procurement strategies for imaging phantom manufacturers and their purchasers. Elevated duties on certain imported components and raw materials prompted firms to reassess supplier footprints, evaluate nearshoring options, and accelerate qualification processes for alternative vendors. In practice, procurement cycles lengthened temporarily as buyers implemented additional compliance checks and sought to understand the total landed cost implications of existing sourcing arrangements.

In response, manufacturers intensified efforts to localize critical processes, particularly those involving high-precision machining, molding, and materials compounding where tariff exposure was most acute. These adjustments often required investments in domestic capacity or the qualification of secondary suppliers in lower-risk jurisdictions. Importantly, the tariff environment has emphasized contractual flexibility and inventory strategy as tactical levers; organizations that maintain responsive logistics and diversified supplier relationships tend to preserve continuity of supply and protect product development timelines. Moving forward, tariffs serve as a catalyst for more robust supply chain design rather than a permanent shift toward protectionism.

In-depth segmentation synthesis revealing how product type material science application focus and end-user behavior converge to dictate engineering choices procurement dynamics and service models

Segmentation analysis illuminates how product type differentiation, material selection, application focus, and end user characteristics shape development priorities and purchasing behavior. Within product typologies, computed tomography-specific phantoms prioritize high-contrast lesion simulation and attenuation accuracy while magnetic resonance phantoms emphasize relaxation parameter fidelity and susceptibility control. Nuclear imaging phantoms require precise activity distribution and attenuation characteristics, whereas PET phantoms must account for coincident event rates and positron range effects. Ultrasound phantoms demand reproducible acoustic impedance and backscatter properties, and X-ray phantoms balance geometric fidelity with radiodensity calibration needs. Each product type therefore drives unique engineering trade-offs and validation protocols that manufacturers must accommodate.

Material choices further influence performance envelopes and lifecycle characteristics. Acrylic and epoxy systems provide stable, machinable platforms suitable for long-term QA tasks, while hydrogel formulations offer tissue-like softness and frequency-dependent acoustic behavior for ultrasound applications. Plastic composites and elastomeric rubbers enable flexible geometries and repeatable mechanical responses, which can be essential for training and simulation modules. The interplay between material properties and intended application-whether equipment testing, quality assurance, research, or training and education-determines acceptable tolerances, aging characteristics, and maintenance requirements.

Application-driven segmentation highlights distinct value propositions. Equipment testing and quality assurance demand rigorous repeatability and traceable calibration standards, emphasizing long-term stability and certifiable performance. Research applications often need customizable, modular phantoms that permit controlled variation of parameters to support hypothesis-driven studies. Training and education prioritize ergonomic realism, cost-effective reproducibility, and safe handling for repeated use. Finally, end users exhibit differentiated procurement behaviors: academic and research institutes typically value configurability and data access for experimentation, diagnostic centers focus on operational reliability and throughput, hospitals emphasize cross-specialty applicability and regulatory compliance, and pharmaceutical companies require phantoms that support imaging biomarker validation and trial reproducibility. Understanding these intersecting segmentation axes enables targeted product strategies and service models that align with stakeholder-specific priorities.

Strategic regional insights across the Americas Europe Middle East and Africa and Asia-Pacific that highlight adoption drivers regulatory priorities manufacturing strengths and procurement patterns

Regional dynamics exert a profound influence on technology adoption, regulatory expectations, and manufacturing strategy across the phantom landscape. In the Americas, innovation centers and established clinical infrastructures drive demand for high-fidelity, regulatory-aligned phantoms that support both device validation and clinical training programs. Procurement processes in this region increasingly emphasize compliance documentation, domestic supply continuity, and vendor transparency, which benefit manufacturers offering certified products and responsive aftermarket services.

Across Europe, the Middle East and Africa, regulatory harmonization efforts and a strong emphasis on clinical standardization create opportunities for phantoms that support cross-border validation and multi-center studies. European markets often prioritize sustainability and lifecycle reporting, encouraging suppliers to document material provenance and end-of-life pathways. In contrast, the Middle East and Africa present a diverse set of clinical maturity levels and infrastructure needs, where scalable, cost-efficient phantoms tailored to training and basic QA programs find strong demand.

Asia-Pacific combines rapid clinical adoption with substantial manufacturing capability, positioning the region as both a major consumer and producer of phantom technologies. Local capabilities in precision manufacturing and materials processing support regional supply chains, while investments in large-scale imaging networks and research initiatives stimulate demand for advanced, modality-specific phantoms. Regional policy priorities, including emissions reduction and supply chain resilience, increasingly shape procurement frameworks and encourage manufacturers to demonstrate both technical performance and environmental stewardship.

Key company insights capturing innovation priorities partnership strategies certification and service differentiation that drive competitive advantage and long-term customer relationships

Company-level dynamics reveal several recurring strategic themes among market participants. First, innovation cycles increasingly revolve around materials engineering and manufacturing flexibility; leaders invest in proprietary composites and fabrication methods that enable rapid customization while preserving validation integrity. Second, partnerships with clinical centers and device OEMs accelerate product refinement and facilitate access to validation data that demonstrate real-world performance. These collaborative pathways shorten feedback loops between development and clinical acceptance.

Third, services and certification pathways offer meaningful differentiation. Companies that couple products with comprehensive calibration services, technical training programs, and documented validation protocols strengthen customer retention and generate recurring revenue streams. Finally, operational excellence in supply chain management and quality systems-especially in regulated jurisdictions-remains a critical factor. Firms that maintain clear traceability, robust change control, and responsive after-sales support tend to secure long-term contracts with large healthcare systems and multinational research consortia.

Practical actionable recommendations for industry leaders to strengthen supply chain resilience accelerate materials innovation expand clinical partnerships and scale service-based differentiation

Industry leaders can act decisively on several fronts to secure sustainable growth and mitigate emerging risks. First, prioritize diversification of supply chains by qualifying multiple suppliers across complementary geographies and by investing selectively in nearshore capabilities for mission-critical components. Such steps reduce exposure to trade policy volatility while preserving development agility. Second, accelerate investment in materials R&D and additive manufacturing capacity to enable higher-fidelity, modality-agnostic phantoms and to shorten design cycles for bespoke applications.

Third, deepen clinical partnerships to co-develop validation protocols and to embed phantoms into early-stage device testing and training curricula; this approach fosters product-market fit and supports adoption. Fourth, enhance service offerings by bundling technical training, calibration, and data packages that demonstrably reduce onboarding time and operational complexity for end users. Fifth, engage proactively with regulatory and standards bodies to influence test methodologies and to ensure that new products align with evolving requirements. Finally, adopt measurable sustainability practices across material sourcing and packaging to meet increasing procurement expectations and to reduce lifecycle environmental impacts.

Transparent and rigorous research methodology describing primary interviews technical validation literature synthesis expert review and triangulation techniques used to ensure reliability and relevance

The research methodology underpinning this analysis combines qualitative and technical approaches to ensure rigor and relevance. Primary evidence comes from structured interviews with clinicians, procurement officers, engineering leads, and materials scientists, which provide contextual understanding of performance expectations and operational constraints. Secondary sources include peer-reviewed literature, standards documentation, and technical white papers that illuminate validation practices and material performance characteristics.

Technical validation involved laboratory evaluations and supplier capability assessments to verify claims about material stability, dimensional accuracy, and modality compatibility. Triangulation across data streams-interviews, technical tests, and literature-supported robust interpretation of trends and reduced single-source bias. Throughout the process, expert panels reviewed draft findings to ensure practical relevance and to highlight areas requiring further investigation. The methodology acknowledges limitations inherent to fast-evolving technologies and recommends periodic reassessment to capture rapid innovation cycles.

Concise concluding synthesis stressing the imperative for integrated investment in materials validation supply chain resilience regulatory alignment and clinical partnerships

In conclusion, the medical imaging phantom sector stands at an inflection point where materials innovation, manufacturing agility, and service-led differentiation determine strategic outcomes. Phantoms increasingly serve as critical enablers for device validation, clinical training, and algorithmic performance assessment, and stakeholders that align product design with modality-specific needs and end-user workflows realize greater adoption. Supply chain resilience and regulatory alignment complement technical excellence, forming the operational foundation necessary for scale.

Decision-makers should therefore focus on integrated strategies that combine technical innovation with robust validation, responsive supply chain design, and strong clinical partnerships. By doing so, organizations can not only manage near-term disruptions but also position themselves to capture the long-term value that accrues to solutions demonstrating repeatable performance, regulatory readiness, and clear operational benefit.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Rising adoption of patient-specific 3D printed phantoms for personalized radiation therapy quality assurance
• 5.2. Increasing integration of artificial intelligence-driven imaging phantoms to standardize CT and MRI performance metrics
• 5.3. Development of multimodal imaging phantoms compatible with MRI, CT, ultrasound and PET for comprehensive scanner calibration
• 5.4. Growing demand for anthropomorphic phantoms simulating pediatric anatomies to optimize dose management in pediatric imaging
• 5.5. Advancements in biomimetic tissue-equivalent materials for high fidelity ultrasound and elastography phantom construction
• 5.6. Expansion of virtual and digital phantom platforms for image reconstruction algorithm validation and clinical workflow training
• 5.7. Collaboration between academic research institutions and manufacturers to design customizable phantoms for novel modality testing
• 5.8. Regulatory emphasis on standardized phantom-based quality control protocols to ensure reproducible imaging performance across facilities

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Imaging Phantoms Market, by Product Type

• 8.1. CT Phantom
• 8.2. MRI Phantom
• 8.3. Nuclear Imaging Phantom
• 8.4. Pet Phantom
• 8.5. Ultrasound Phantom
• 8.6. X-Ray Phantom

9. Medical Imaging Phantoms Market, by Material

• 9.1. Acrylic
• 9.2. Epoxy
• 9.3. Hydrogel
• 9.4. Plastic
• 9.5. Rubber

10. Medical Imaging Phantoms Market, by Application

• 10.1. Equipment Testing
• 10.2. Quality Assurance
• 10.3. Research
• 10.4. Training & Education

11. Medical Imaging Phantoms Market, by End User

• 11.1. Academic & Research Institutes
• 11.2. Diagnostic Centers
• 11.3. Hospitals
• 11.4. Pharmaceutical Companies

12. Medical Imaging Phantoms Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Medical Imaging Phantoms Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Medical Imaging Phantoms Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Computerized Imaging Reference Systems, Inc.
  • 15.3.2. Sun Nuclear Corporation
  • 15.3.3. Standard Imaging, Inc.
  • 15.3.4. Kyoto Kagaku Co., Ltd.
  • 15.3.5. Modus Medical Devices Inc.
  • 15.3.6. PTW-Freiburg GmbH
  • 15.3.7. Phantom Laboratory, Inc.
  • 15.3.8. Tissue Simulation Technology, LLC
  • 15.3.9. Radiation Imaging Technology, Inc.
  • 15.3.10. Fluke Biomedical

LIST OF FIGURES

• FIGURE 1. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. MEDICAL IMAGING PHANTOMS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. MEDICAL IMAGING PHANTOMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. MEDICAL IMAGING PHANTOMS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 129. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 130. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 131. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 132. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 133. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 134. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 135. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 136. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 137. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 138. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 139. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 142. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 143. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 144. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 145. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 146. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 147. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 148. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 149. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 150. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 151. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 152. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 153. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 154. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 155. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 156. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 157. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 158. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 161. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 162. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 163. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 164. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 165. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 166. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 167. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 168. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 169. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 170. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 171. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 172. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 173. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 174. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 175. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 176. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 177. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 178. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 179. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 180. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 181. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 182. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 183. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 184. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 185. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 186. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 187. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 188. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 189. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 190. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 191. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 192. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 193. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 194. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 195. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 196. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 197. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 198. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 199. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 200. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 201. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 202. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 203. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 204. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 205. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 206. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 207. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 208. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 209. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 210. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 211. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 212. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 213. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 214. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 215. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 216. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 217. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 218. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 219. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 220. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 221. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 222. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 223. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 224. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 225. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 226. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 227. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 228. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 229. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 230. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 231. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 232. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 233. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 234. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 235. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 236. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 237. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 238. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 239. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 240. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 241. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 242. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 243. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 244. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 245. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 246. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 247. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 248. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 249. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 250. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 251. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 252. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 253. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 254. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 255. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 256. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 257. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 258. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 259. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 260. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 261. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 262. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 263. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 264. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 265. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 266. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 267. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 268. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 269. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 270. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 271. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 272. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 273. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 274. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 275. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 276. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 277. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 278. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 279. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 280. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 281. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 282. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 283. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 284. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 285. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 286. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 287. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 288. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 289. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 290. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 291. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 292. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 293. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 294. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 295. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 296. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 297. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 298. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 299. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 300. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 301. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 302. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 303. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 304. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 305. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 306. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 307. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 308. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 309. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 310. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 311. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 312. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 313. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 314. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 315. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 316. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 317. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 318. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 319. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 320. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 321. FRANCE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 322. FRANCE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 323. FRANCE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 324. FRANCE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 325. FRANCE MEDICAL IMAGING PHANTOMS MARKET SIZE, B